Boadie Waid Dunlop MD

Psychiatry•Atlanta, GA

Director of the Mood and Anxiety Disorders Program (MAP); and Associate Professor of Psychiatry and Behavioral Sciences, Emory University.

Join to View Full Profile

12 Executive Park Dr. NE3rd FloorAtlanta, GA 30329
Phone+1 404-727-8474
Fax+1 404-727-3700

Education & Training

Emory University School of MedicineResidency, Psychiatry, 1997 - 2001
Mayo Clinic College of MedicineClass of 1997

Certifications & Licensure

FL State Medical License 2021 - Present
GA State Medical License 1998 - 2025
NC State Medical License 2020 - 2022
American Board of Psychiatry and Neurology Psychiatry

Clinical Trials

Thyroid Medication and Antidepressants for Treating Major Depression Start of enrollment: 1996 Sep 01
Completed
Phase 4
Identifying Factors That Predict Antidepressant Treatment Response Start of enrollment: 2006 Aug 01
Completed
Not Applicable
Evaluation of GSK561679 in Women With Post-Traumatic Stress Disorder Start of enrollment: 2009 Dec 01
Completed
Phase 2
Decision-Making in Bipolar Disorder Start of enrollment: 2011 May 01
Completed
Not Applicable
Effects of Treatment on Decision-making in Major Depression Start of enrollment: 2013 Aug 01
Completed
Phase 4
Efficacy of Swedish Massage Therapy on Cancer-related Fatigue in Cancer Survivors Start of enrollment: 2013 Nov 01
Completed
Phase 2
Genomics Used to Improve DEpression Decisions Start of enrollment: 2014 Apr 01
Completed
Not Applicable
The ISLAND Study: InSuLa Assessed Needs for Depression Start of enrollment: 2014 Sep 01
Completed
Phase 4
Vortioxetine for Posttraumatic Stress Disorder Start of enrollment: 2016 Dec 01
Completed
Phase 4
Tapering Off Antidepressants Start of enrollment: 2016 Jan 01
Terminated
Not Applicable
Artificial Intelligence in Depression - Medication Enhancement Start of enrollment: 2022 Jun 16
Completed
Not Applicable
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Metabolomics signatures of serotonin reuptake inhibitor (escitalopram), serotonin norepinephrine reuptake inhibitor (duloxetine) and cognitive-behavioral therapy on ke...
Sudeepa Bhattacharyya, Siamak MahmoudianDehkordi, Matthew J Sniatynski, Marina Belenky, Vasant R Marur
Journal of Affective Disorders. 2025-04-15
Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive Disorder.
Guy M Goodwin, Ania Nowakowska, Merve Atli, Boadie W Dunlop, David Feifel
The Journal of Clinical Psychiatry. 2025-03-03
1 citations
Sustained effects of repeated levodopa (L-DOPA) administration on reward circuitry, effort-based motivation, and anhedonia in depressed patients with higher inflammation.
Mandakh Bekhbat, Zhihao Li, Boadie W Dunlop, Michael T Treadway, Neeti D Mehta
Brain, Behavior, and Immunity. 2025-03-01

Journal Articles

Response Rate Profiles for Major Depressive Disorder: Characterizing Early Response and Longitudinal Nonresponse
Charles B Nemeroff, W Edward Craighead, Helen S Mayberg, Boadie W Dunlop, Depression and Anxiety

Authored Content

F179. Epigenetic Biomarkers in Women with Posttraumatic Stress Disorder After CRF1 Receptor Antagonist TreatmentApril 2018
F179. Epigenetic Biomarkers in Women with Posttraumatic Stress Disorder After CRF1 Receptor Antagonist TreatmentApril 2018

Press Mentions

Emory Expands PTSD Research with $4.9M DoD-Funded MDMA StudyMarch 4th, 2025
Researchers to Test Psychedelic Drug plus Therapy to Help Military Members with PTSDFebruary 27th, 2025
Attitudes Toward Psychedelic Therapy Reveal Both Promise and CautionDecember 17th, 2024
Join now to see all

Grant Support

Neural Correlates Of Loss Aversion In Major DepressionNational Institute Of Mental Health2009–2011